MUFG Securities EMEA’s ResMed RMD Stock Holding History

MUFG Securities EMEA’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.11M	Sell	5,704 -280	-5%	-$58K	0.01%	399
2026 Q1	$1.34M	Hold	5,984	–	–	0.02%	342
2025 Q4	$1.44M	Buy	5,984 +3,182	+114%	+$814K	0.02%	353
2025 Q3	$767K	Buy	2,802 +2,369	+547%	+$647K	0.02%	294
2025 Q2	$112K	Buy	+433	New	+$103K	﹤0.01%	298
2021 Q2	–	Sell	-2,026	Closed	-$393K	–	396
2021 Q1	$393K	Buy	+2,026	New	+$406K	﹤0.01%	324
2018 Q4	–	Sell	-3,870	Closed	-$446K	–	670
2018 Q3	$446K	Sell	3,870 -22,290	-85%	-$2.44M	0.01%	488
2018 Q2	$2.71M	Buy	+26,160	New	+$2.65M	0.05%	180

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

MUFG Securities EMEA's RMD Position: Q2 2026 in Review

MUFG Securities EMEA reduced its ResMed (RMD) stake by 4.7% in Q2 2026, selling an estimated $58K and leaving 5,704 shares worth $1.11M. The position accounts for 0.01% of the portfolio, ranked #399.

MUFG Securities EMEA first reported a position in RMD in Q2 2018 and has held it in 8 quarters since. The position peaked at $2.71M in Q2 2018. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

MUFG Securities EMEA held 5,704 shares of ResMed worth $1.11M as of Q2 2026.
MUFG Securities EMEA sold 280 ResMed shares in Q2 2026, an estimated $58K.
ResMed made up 0.01% of MUFG Securities EMEA's portfolio in Q2 2026, its #399 holding.
MUFG Securities EMEA first reported a position in ResMed in Q2 2018 and has held it in 8 quarters since.
MUFG Securities EMEA's ResMed position peaked at $2.71M in Q2 2018.
882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on MUFG Securities EMEA's 13F filing for Q2 2026, filed 12 Aug 2026.